Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study.

Abstract

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (alloHCT) remains a major therapeutic challenge. We studied outcomes of 1788 AML patients relapsing after alloHCT (1990 to 2010) during first or second complete remission (CR) to identify factors associated with longer postrelapse survival. Median time to post-HCT… (More)
DOI: 10.1016/j.bbmt.2014.11.007

Topics

Cite this paper

@article{Bejanyan2015SurvivalOP, title={Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study.}, author={Nelli Bejanyan and Daniel J. Weisdorf and Brent Logan and Hailin Wang and Steven M. Devine and M de Lima and Donald Bunjes and Mei-Jie Zhang}, journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation}, year={2015}, volume={21 3}, pages={454-9} }